Mr. Speaker, I listened closely to my colleague's speech, which was very eloquent and relevant. We know that 70% of intravenous drug users who use InSite are less likely to share needles, and reducing needle sharing has been listed as an international best practice to reduce HIV/AIDS, hepatitis B and hepatitis C. However, since we began debating this bill, we have noticed that our colleagues on the government benches have adopted the ostrich approach, meaning they simply stick their heads in the oil sands instead of thinking about the health and safety of Canadians.
Should they not be more realistic and come back down to earth?